Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era

By Ung J.O.   Richie J.P.   Chen M.-H.   Renshaw A.A.   D'Amico A.V.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 458-463

Elsevier

Access to resources Recommend Favorite

Comparison of oncologic outcomes after radical prostatectomy in men diagnosed with prostate cancer with PSA levels below and above 4 ng/mL

By Dariane Charles   Cossec Chloé   Drouin Sarah   Wolff Benoit   Granger Benjamin   Mozer Pierre   Bitker Marc-Olivier   Shariat Shahrokh   Cussenot Olivier   Rouprêt Morgan  

World Journal of Urology, Vol. 32, Iss. 2, 2014-04 ,pp. : 481-487

Springer Publishing Company

Access to resources Recommend Favorite

Use of serum concentration techniques to enhance early detection of recurrent prostate cancer after radical prostatectomy

By Pruthi R.S.   Haese A.   Huland E.   Stamey T.A.  

Urology, Vol. 49, Iss. 3, 1997-05 ,pp. : 404-410

Elsevier

Access to resources Recommend Favorite

Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database

By The SEARCH Database Study Group   Freedland S.J.   Aronson W.J.   Csathy G.S.   Kane C.J.   Amling C.L.   Presti J.C.   Dorey F.   Terris M.K.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 742-747

Elsevier

Access to resources Recommend Favorite

Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the center for prostate disease research nomograms

By Gancarczyk K.J.   Wu H.   McLeod D.G.   Kane C.   Kusuda L.   Lance R.   Herring J.   Foley J.   Baldwin D.   Bishoff J.T.   Soderdahl D.   Moul J.W.  

Urology, Vol. 61, Iss. 3, 2003-03 ,pp. : 589-595

Elsevier

Access to resources Recommend Favorite